Clinical Trial Update: A Clinical Trial of SIBP-A16 Injection in Healthy Adults [EARLY_Phase 1]

View source ↗

Summary

This entry reports an early-phase 1 clinical trial of SIBP-A16 Injection in healthy adults, evaluating safety for potential use against respiratory syncytial vi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• SIBP-A16 Injection

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Respiratory Syncytial Virus (RSV) | EARLY_Phase 1 | Status: RECRUITING